Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-07-26

Clinical Trial Update: Effect of Probenecid on Synovial Fluid ATP Levels in CPPD [EARLY_Phase 1]

View source ↗

Summary

Early-phase trial evaluating the effect of probenecid on synovial fluid ATP levels in calcium pyrophosphate deposition disease has completed with results posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Probenecid (probenecid)

Snippet

Sponsor: VA Office of Research and Development | Conditions: Calcium Pyrophosphate Deposition Disease | EARLY_Phase 1 | Status: COMPLETED | Results posted: 2022-07-26